Source comparison
TB-500 Injection Frequency: Protocol Comparison
Daily Loading → Every-Other-Day Maintenance 2–5mg daily for 14–21 days 2–5mg every other day for 4–8 weeks 6–10 weeks total Saturation by day 18–21 in muscle; 24–28 in tendon Fastest observable response—front-loads tissue accumulation, then sustains levels wit
This comparison does not assign a generated winner or score.
- Daily Loading → Every-Other-Day Maintenance
- 2–5mg daily for 14–21 days
- 2–5mg every other day for 4–8 weeks
- 6–10 weeks total
- Saturation by day 18–21 in muscle; 24–28 in tendon
- Fastest observable response—front-loads tissue accumulation, then sustains levels without receptor downregulation. Standard for acute injury models.
- Flat Every-Other-Day from Start
- N/A (no distinct loading)
- 2–5mg every other day for 8–12 weeks
- 8–12 weeks total
- Saturation by day 28–35 in muscle; 35–42 in tendon
- Slower to threshold—tissue levels build gradually. Works for low-severity or chronic conditions where rapid saturation isn't critical.
- Daily Throughout (No Transition)
- 2–5mg daily for entire protocol
- N/A (continuous daily)
- 4–8 weeks total
- Saturation by day 18–21, but receptor downregulation risk after 28 days
- Higher peptide consumption with diminishing returns post-saturation. Use only for short-term protocols (<4 weeks) or when rapid loading is essential and duration is limited.
- Twice-Weekly Maintenance Only
- N/A (no loading phase)
- 2–5mg twice per week for 8–12 weeks
- Saturation uncertain—may never reach threshold in low-metabolic tissues
- Insufficient for acute repair—works only for preventive or very mild conditions. Not recommended for tissue remodeling goals.